Hypoglycemia Prevention and Awareness Program

Last updated: January 9, 2025
Sponsor: Merve DerviAYoAYlu
Overall Status: Active - Not Recruiting

Phase

N/A

Condition

Parathyroid Disorders

Diabetic Macular Edema

Diabetes (Pediatric)

Treatment

Hypoglycemia prevention and awareness program (HypoPAP)

Clinical Study ID

NCT06775288
DokuzEU-IHH-MD-01
  • Ages > 18
  • All Genders

Study Summary

The aim of this project is to examine the effects of the Hypoglycemia Prevention and Awareness Program (HypoPAP) on patient outcomes, including metabolic, psychological, social, and economic parameters, in individuals with type 2 diabetes and impaired hypoglycemia awareness.

Through the interventions provided to participants, the study aims to achieve the following improvements:

  • Physiological parameters: Enhanced glycemic control, reduced hypoglycemia frequency, improved hypoglycemia awareness, and optimized HbA1c levels.

  • Psychological parameters: Reduced fear of hypoglycemia, increased hypoglycemic confidence, and improved attitudes toward hypoglycemia management.

  • Social parameters: Decreased social withdrawal due to fear of hypoglycemia, as assessed through relevant items in validated scales.

  • Economic parameters: Reduced frequency of hospitalizations and emergency department visits.

Overall, the program seeks to enhance participants' ability to prevent and manage hypoglycemia, thereby improving their overall well-being.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Being 18 years of age and older

  • Being able to communicate in Turkish

  • Being diagnosed with type 2 diabetes

  • Having used insulin for at least one year

  • Having reduced hypoglycemia awareness

  • Being willing to participate in the study

  • Having and being able to use information technology products (telephone, computer).

Exclusion

Exclusion Criteria:

  • Having visual, auditory, cognitive impairment

  • Having a condition that prevents communication

  • Not being able to use information technology products

  • Having chronic renal failure, chronic vascular disease, chronic liver disease,cancer

  • Pregnancy

  • Endocrine and eating disorders

  • Individuals who do not agree to participate in the study

  • Do not meet the inclusion criteria will not be included.

Study Design

Total Participants: 62
Treatment Group(s): 1
Primary Treatment: Hypoglycemia prevention and awareness program (HypoPAP)
Phase:
Study Start date:
November 01, 2024
Estimated Completion Date:
April 15, 2025

Study Description

Optimal diabetes management is a delicate balance between treating hyperglycemia and avoiding the risk of sudden hypoglycemia. Hypoglycemia is a common, recurring, feared, and neglected complication among endocrine emergencies in individuals with diabetes. Intensive glycemic control is very important in preventing microvascular and macrovascular complications of diabetes. However, hypoglycemia is a significant obstacle to effective treatment. Individuals with diabetes experience many chronic microvascular and macrovascular complications. The most challenging and frightening complication for individuals with diabetes and their families is hypoglycemia. Diabetics are afraid of experiencing hypoglycemia, and fear of hypoglycemia is a significant obstacle to achieving normoglycemia. Hypoglycemia in individuals with type 2 diabetes often occurs due to errors in self-management. Hypoglycemia limits the physical activities and daily living activities of individuals with diabetes. Hypoglycemia, which negatively affects the physiological and psychological health of individuals with diabetes, also reduces the quality of life of patients and their families. Hypoglycemia is also the most important limitation of diabetes treatment. As the severity of hypoglycemia increases, the quality of life of patients decreases. Approximately 25% of patients with type 2 diabetes treated with insulin for more than five years experience severe hypoglycemia. Impaired awareness of hypoglycemia is the weakening of the ability to perceive warning signs during hypoglycemia. Impaired awareness of hypoglycemia is associated with a 6- to 9-fold increase in the risk of severe hypoglycemia. Recurrent hypoglycemia, defined as the occurrence of more than one hypoglycemic event, increases the risk of severe hypoglycemia, and this also reduces hypoglycemia awareness. Before implementing strategies to help increase hypoglycemia awareness in individuals with diabetes, it is important to identify individuals who are at risk for severe hypoglycemia or have decreased hypoglycemia awareness. The risk of severe hypoglycemia is highest in individuals who have had a severe hypoglycemic episode in the past or in patients with reduced awareness of hypoglycemia. Comprehensive interventions need to be developed to increase hypoglycemia awareness in diabetic patients. While structured and comprehensive hypoglycemia awareness training is limited even for individuals with type 1 diabetes in the literature, there is no training program specifically developed for type 2 diabetes. In line with this information, it is necessary to develop a structured training program for individuals with type 2 diabetes and reduced hypoglycemia awareness and evaluate its effectiveness. Therefore, the aim of this study is to examine the effect of the hypoglycemia prevention and awareness program (HypoPAP) on patient outcomes in individuals with type 2 diabetes with decreased hypoglycemia awareness. The study was planned as a randomized controlled study.

Connect with a study center

  • Dokuz Eylül University

    İzmir, 35640
    Turkey

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.